Cases & Deals

Share

Celularity raises capital in Series A round

August 2017

Client(s) Celularity, Inc.

Jones Day represented Celularity Inc., a biotechnology company that sources and develops transformative therapies derived from the placenta, in connection with its issuance of Series A Convertible Preferred Stock in a private placement to strategic and entrepreneurial investors.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.